Categories
Type at least 2 characters to search.
View all results →
Champions Oncology
About CRO
Specialized preclinical CRO providing tumor growth inhibition studies and translational oncology services using patient-derived xenograft models. Their preclinical lab services include flow cytometry, FACS cell sorting, tumor immunophenotyping, and immune cell characterization for oncology drug development.
Technology & Expertise
Our Preclinical & Nonclinical Studies, Drug Discovery & Development, Laboratory Services capabilities are central to the work we deliver at Champions Oncology. Programs can draw on nonclinical programs supporting candidate selection and regulatory milestones; integrated discovery workflows spanning target assessment through candidate development; study-specific laboratory workflows supported by controlled methods and data review, with methods and resources selected for the required phase, geography, and data package.
Core Services
We provide tailored support in Preclinical & Nonclinical Studies, Drug Discovery & Development, Laboratory Services. Each Champions Oncology engagement can combine in vitro and in vivo study design, safety assessment, and translational evaluation; screening, lead optimization, translational science, and development planning; laboratory testing, method execution, sample analysis, and scientific reporting, configured for the required study phase, markets, and internal sponsor resources.
Accreditations & Compliance
At Champions Oncology, quality requirements are defined for the service, facility, jurisdiction, and study scope. We provide current certificates and site-specific documentation for review during vendor qualification.
